Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease

• Raghav Oberoi ,

  Contributed equally to this work with: Raghav Oberoi, Eskindir P. Bogalle

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Eskindir P. Bogalle ,

  Contributed equally to this work with: Raghav Oberoi, Eskindir P. Bogalle

  Affiliation Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

  ⨯
• Lukas A. Matthes,

  Affiliation Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

  ⨯
• Harald Schuett,

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Ann-Kathrin Koch,

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Karsten Grote,

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Bernhard Schieffer,

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Jutta Schuett ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯
• Maren Luchtefeld

  * E-mail: Maren.Luchtefeld@gmx.de

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany

  ⨯